Talmadge JE - Search Results

1

Activation-induced T cell apoptosis by monocytes from stem cell products.

Ino K, Ageitos AG, Singh RK, Talmadge JE. Ino K, et al. Among authors: talmadge je. Int Immunopharmacol. 2001 Jul;1(7):1307-19. doi: 10.1016/s1567-5769(01)00062-5. Int Immunopharmacol. 2001. PMID: 11460311

2

Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2.

Ozerol I, Ageitos A, Heimann DG, Talmadge JE. Ozerol I, et al. Among authors: talmadge je. Int J Immunopharmacol. 1999 Aug;21(8):509-21. doi: 10.1016/s0192-0561(99)00029-6. Int J Immunopharmacol. 1999. PMID: 10458540

3

Mechanisms of immune dysfunction in stem cell transplantation.

Talmadge JE, Singh R, Ino K, Ageitos A, Buyukberber S. Talmadge JE, et al. Int J Immunopharmacol. 2000 Dec;22(12):1041-56. doi: 10.1016/s0192-0561(00)00078-3. Int J Immunopharmacol. 2000. PMID: 11137611 Clinical Trial.

4

Immune reconstitution after autologous hematopoietic transplantation with Lin-, CD34+, Thy-1lo selected or intact stem cell products.

Singh RK, Varney ML, Leutzinger C, Vose JM, Bierman PJ, Buyukberber S, Ino K, Loh K, Nichols C, Inwards D, Rifkin R, Talmadge JE. Singh RK, et al. Among authors: talmadge je. Int Immunopharmacol. 2007 Aug;7(8):1033-43. doi: 10.1016/j.intimp.2007.03.006. Epub 2007 Apr 20. Int Immunopharmacol. 2007. PMID: 17570320 Free PMC article. Clinical Trial.

5

Monocytes from mobilized stem cells inhibit T cell function.

Ino K, Singh RK, Talmadge JE. Ino K, et al. Among authors: talmadge je. J Leukoc Biol. 1997 May;61(5):583-91. doi: 10.1002/jlb.61.5.583. J Leukoc Biol. 1997. PMID: 9129207

6

Restoration of T and NK cell function in GM-CSF mobilized stem cell products from breast cancer patients by monocyte depletion.

Ageitos AG, Ino K, Ozerol I, Tarantolo S, Heimann DG, Talmadge JE. Ageitos AG, et al. Among authors: talmadge je. Bone Marrow Transplant. 1997 Jul;20(2):117-23. doi: 10.1038/sj.bmt.1700864. Bone Marrow Transplant. 1997. PMID: 9244414

7

IL-2 expansion of T and NK cells from growth factor-mobilized peripheral blood stem cell products: monocyte inhibition.

Ageitos AG, Singh RK, Ino K, Ozerol I, Tarantolo S, Reed EK, Talmadge JE. Ageitos AG, et al. Among authors: talmadge je. J Immunother. 1998 Nov;21(6):409-17. doi: 10.1097/00002371-199811000-00002. J Immunother. 1998. PMID: 9807735

8

Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products.

Singh RK, Ino K, Varney ML, Heimann DG, Talmadge JE. Singh RK, et al. Among authors: talmadge je. Bone Marrow Transplant. 1999 Jan;23(1):53-62. doi: 10.1038/sj.bmt.1701518. Bone Marrow Transplant. 1999. PMID: 10037051

9

Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products.

Ageitos AG, Varney ML, Bierman PJ, Vose JM, Warkentin PI, Talmadge JE. Ageitos AG, et al. Among authors: talmadge je. Bone Marrow Transplant. 1999 Jan;23(1):63-9. doi: 10.1038/sj.bmt.1701524. Bone Marrow Transplant. 1999. PMID: 10037052

10

Expression of interleukin-10 in isolated CD8+ T cells and monocytes from growth factor-mobilized peripheral blood stem cell products: a mechanism of immune dysfunction.

Varney ML, Ino K, Ageitos AG, Heimann DG, Talmadge JE, Singh RK. Varney ML, et al. Among authors: talmadge je. J Interferon Cytokine Res. 1999 Apr;19(4):351-60. doi: 10.1089/107999099314054. J Interferon Cytokine Res. 1999. PMID: 10334386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

257 results

Search Page